Cohesion and empowerment! Shandong Guoxin and his entourage visited Yinfeng Cryogenic Medical Research Center for visits and exchanges
Release time:
2023-09-05
On September 5th, Zhou Peng and Zhao Quanan, general managers of Jinan Yinfeng Wealth Center of Shandong International Trust Co., Ltd., and Yang Qin, an expert of Beijing family office trust, visited the Cryogenic Medicine Research Center of Shandong Yinfeng Life Science Research Institute.
During the visit, Shandong Guoxin and his entourage learned in detail about the scientific research progress and application prospects of cryogenic medicine, learned for the first time about the history of Yinfeng's life extension program and the story behind "Asia's first human cryopreservation", and expressed concern and recognition for this forward-looking and challenging research project, and looked forward to the future vision and bright future of cryogenic medicine.
Subsequently, at the symposium, the Yinfeng cryogenic medical team comprehensively introduced the operation, business sectors and scientific research development of Yinfeng Group and the Cryogenic Medical Research Center; Shandong Guoxin and his entourage introduced the comprehensive strength and business layout of Shandong Guoxin Company in depth. At the same time, the two sides discussed the integration of resource advantages and service models, in order to find opportunities, promote model innovation, empower each other, and provide better services for members of both sides.
Through this visit and exchange, the two sides initially reached a cooperation intention, which laid a good foundation for the next step of cross-industry cooperation.
相关介绍
Shandong International Trust Co., Ltd. (hereinafter referred to as "Shandong Guoxin"), established in 1987, is a non-bank financial institution approved by the People's Bank of China and the People's Government of Shandong Province. As a comprehensive financial service institution controlled by Luxin Group, Shandong Guoxin was listed on the Hong Kong Stock Exchange in December 2017, becoming the first mainland trust to land in the international capital market and the first Hong Kong stock trust.
Shandong Guoxin has always adhered to the principle of seeking progress while maintaining stability and improving quality, comprehensively using a variety of financial tools to serve economic and social development, effectively grafting the money market, capital market and real economy, and building a development pattern of "rooted in Shandong, radiating the whole country and going international", and has won the highest grade A in China's trust industry rating and the highest AAA grade in the performance evaluation of local financial enterprises in Shandong Province for many times, and has developed into a comprehensive financial and wealth management service provider with leading comprehensive strength and high brand reputation.
Latest developments
The debut and discourse of the YinFeng Life Continuation Project not only served as an authoritative demonstration of its own ethical governance framework but also contributed practical wisdom toward establishing industry norms.
Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross
Looking ahead, Yinfeng Foundation will use this recognition as an opportunity to further deepen its strategic collaboration with the Jinan Red Cross, expand cooperation in areas such as life health and emergency response, and continue to empower efforts to accelerate the construction of a "new, strong, excellent, rich, beautiful, and high-quality" modern socialist strong capital city, contributing even more Yinfeng strength to this endeavor.
The team successfully developed the CryoSIM platform, an intelligent microfluidics and deep learning-integrated system. This platform deeply integrates core technologies of deep learning and microfluidics to enable high-throughput, high-precision automated analysis of oocyte membrane permeability. It provides a novel technological tool for optimizing and advancing the clinical translation of oocyte cryopreservation techniques. Additionally, it offers an innovative practical paradigm for the application of artificial intelligence in low-temperature biomedicine and reproductive medicine.
Public Welfare Partnership: A Special Letter from the Jinan Red Cross
On the afternoon of January 30, 2026, the Jinan Red Cross presented a letter of special significance to the Shandong Yinfeng Life Science Public Welfare Foundation (hereinafter referred to as the Yinfeng Foundation).
World’s First Achievement Highlights Brand Leadership
In the future, Yinfeng Life Science Research Institute will continue to uphold its mission of "Dedicated to Medical Technology, Safeguarding Human Health." It will empower brand building with more original and pioneering scientific and technological achievements, contributing wisdom and strength to Shandong's goal of building a national regional innovation hub and promoting Chinese brands on the global stage.
Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference
Currently, the ovarian tissue dual activation technology has been successfully applied in clinical practice at Beijing University of Chinese Medicine Shenzhen (Longgang) Hospital, having treated over 400 patients with a treatment success rate of 70%. Over the next three years, Shandong Yinfeng Life Science Research Institute plans to use Jinan as a center to gradually expand the transformation and application of this technological achievement nationwide.
Yinfeng Life Continuation Plan
Address: Yinfeng Biotechnology Park, 1758 Gangyuan 6th Road, High-tech Zone, Jinan City, Shandong Province
Zip Code: 250102
Telephone: 0086-0531-88897351
Mobile: 0086-19953155515
Mobile website
Official WeChat Public Number
Links:Red Cross Society of China丨Shandong Red Cross Society丨Shandong Provincial Health Commission | Yinfeng Group| Yinfeng Biological Group
All rights reserved©Yinfeng Life Continuation Powered by www.300.cn SEO
